BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27893184)

  • 1. Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.
    Fabbri C; Boriani G; Diemberger I; Filippi MG; Ravegnini G; Hrelia P; Minarini A; Albani D; Forloni G; Angelini S; Serretti A
    Basic Clin Pharmacol Toxicol; 2017 May; 120(5):482-490. PubMed ID: 27893184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation.
    Corponi F; Fabbri C; Boriani G; Diemberger I; Albani D; Forloni G; Serretti A
    Neuropsychobiology; 2019; 77(2):67-72. PubMed ID: 30544110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.
    Nosè M; Bighelli I; Castellazzi M; Martinotti G; Carrà G; Lucii C; Ostuzzi G; Sozzi F; Barbui C;
    Epidemiol Psychiatr Sci; 2016 Dec; 25(6):532-540. PubMed ID: 26467074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants/Predictors of QT Abnormalities in Patients on Psychotropic Medications in a Nigerian Tertiary Hospital.
    Ojo OE; Ajayi EA; Ajayi AO; Fadare JO; Dada SA; Olaoye OB
    Cardiovasc Toxicol; 2024 Jul; 24(7):700-709. PubMed ID: 38819736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.
    Spellmann I; Reinhard MA; Veverka D; Zill P; Obermeier M; Dehning S; Schennach R; Müller N; Möller HJ; Riedel M; Musil R
    Eur Arch Psychiatry Clin Neurosci; 2018 Jun; 268(4):383-390. PubMed ID: 29429138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
    Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia.
    Polcwiartek C; Kragholm K; Hansen SM; Atwater BD; Friedman DJ; Barcella CA; Graff C; Nielsen JB; Pietersen A; Nielsen J; Søgaard P; Torp-Pedersen C; Jensen SE
    Schizophr Bull; 2020 Feb; 46(2):354-362. PubMed ID: 31219596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychotropic drugs and QTc prolongation].
    De Wit LE; van Stiphout F; Groeneveld SA; Hassink RJ; Dekker D
    Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-generation antipsychotics and QTc: any role for mediating variables?
    Carrà G; Crocamo C; Bartoli F; Lax A; Tremolada M; Lucii C; Martinotti G; Nosè M; Bighelli I; Ostuzzi G; Castellazzi M; Clerici M; Barbui C;
    Hum Psychopharmacol; 2016 Jul; 31(4):313-8. PubMed ID: 27245736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for QT prolongation associated with acute psychotropic drug overdose.
    Miura N; Saito T; Taira T; Umebachi R; Inokuchi S
    Am J Emerg Med; 2015 Feb; 33(2):142-9. PubMed ID: 25445869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.
    Barbui C; Bighelli I; Carrà G; Castellazzi M; Lucii C; Martinotti G; Nosè M; Ostuzzi G;
    PLoS One; 2016; 11(2):e0148212. PubMed ID: 26840602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety Limits of Antidepressant Use Plus Combinations: Focus on Cardiovascular Function.
    Stella F; Loureiro JC; Pais MV; Canineu PR; Forlenza OV
    Curr Drug Metab; 2018; 19(8):641-652. PubMed ID: 29283067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QTc interval diurnal variations in patients treated with psychotropic medications: implications for the evaluation of drug induced QTc changes.
    Cuomo A; Libri C; Barillà G; Cattolico M; Carmellini P; Fagiolini A
    Int Rev Psychiatry; 2022; 34(7-8):689-692. PubMed ID: 36786118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncardiac drugs and QTc interval prolongation: an often unrecognized risk factor for adverse cardiovascular outcomes.
    Sander GE; Guillory GS; Giles TD
    Am J Geriatr Cardiol; 2002; 11(3):197-202. PubMed ID: 11986537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.